Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A

Background The diagnosis of acute hepatitis A virus (HAV) infection is made on the basis of the presence of anti-HAV immunoglobulin M (IgM) antibodies in patients with clinical features of acute hepatitis. Some patients show a negative serology at initial presentation, which may complicate the diagnosis of hepatitis A (HA). The aim of this study was to examine the characteristics of HA patients with an initially negative anti-HAV IgM test result. Materials and methods Patients with symptomatic acute hepatitis who underwent IgM anti-HAV testing at a single center were enrolled consecutively, with tests repeated in patients with negative initial serology. Results A total of 684 patients with acute hepatitis were tested, of whom 620 patients were initially or eventually diagnosed with HA. Anti-HAV IgM was initially negative in 67 of the 620 HA patients (10.9%), but was later confirmed by subsequent retests. These patients had on average a shorter time lapse from the onset of symptoms to the initial test, a higher rate of fever, and lower alanine aminotransferase and bilirubin levels compared with those with a positive initial serology. Cutoff index (COI) values of anti-HAV IgM were correlated positively with the duration of time from the onset of symptoms to the initial test. Fever, lower bilirubin levels, and higher COI values were predictive of seroconversion to anti-HAV positivity in patients with a negative initial serology. Conclusion Taking into account the window period of HAV infection, anti-HAV IgM tests should be repeated, particularly in patients with features of the initial phase of hepatitis and a high COI value of anti-HAV IgM.

[1]  Chang Duck Kim,et al.  Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test , 2012, The Korean journal of hepatology.

[2]  S. Pol,et al.  Acute hepatitis A virus infection without IgM antibodies to hepatitis A virus. , 2011, Annals of internal medicine.

[3]  Y. Jee,et al.  Atypical manifestations of hepatitis A infection: A prospective, multicenter study in Korea , 2010, Journal of medical virology.

[4]  J. Cha,et al.  Factors for Predicting Positive Results for Anti-HAV IgM Retesting Among Initially Seronegative Patients , 2010, Digestive Diseases and Sciences.

[5]  C. Chu,et al.  Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak , 1986, Infection.

[6]  L. Villar,et al.  Detection of hepatitis A virus RNA in serum during the window period of infection. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  P. Chatchatee,et al.  Epidemiology and prophylaxis of viral hepatitis:A global perspective , 2002, Journal of gastroenterology and hepatology.

[8]  J. Yeon,et al.  VIRAL HEPATITIS, LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA Detection of hepatitis A viral RNA in sera of patients with acute hepatitis A , 2000 .

[9]  H. Margolis,et al.  Duration of viremia in hepatitis A virus infection. , 2000, The Journal of infectious diseases.

[10]  L. Gürtler Difficulties and strategies of HIV diagnosis , 1996, The Lancet.

[11]  H. Reesink,et al.  Hepatitis C virus six years on , 1994, The Lancet.

[12]  H. Margolis,et al.  Worldwide epidemiology of hepatitis A virus infection. , 1993, Journal of hepatology.

[13]  A. Redeker,et al.  The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A , 1984, Hepatology.

[14]  D. Bradley,et al.  Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay , 1977, Journal of clinical microbiology.